CP and COVID-19: The study reported no severe unpropitious effects, and suggested that CP therapy could possibly ameliorate the clinical outcomes by neutralizing viraemia in patients with critical SARS-CoV-2 infection and can serve as a promising rescue option for severe cases of COVID-19 [54].